RIJSWIJK, NETHERLANDS and IRVINE, CA, AMSTERDAM, – Bluebee, a company driving global genomic data-driven medicine, and Agendia, Inc, a world leader in personalized medicine and molecular cancer diagnostics, have partnered to provide a secure, convenient, data processing solution for Agendia’s MammaPrint BluePrint Breast Cancer Recurrence and Molecular Subtyping Kit, which is intended for prognostic use […]
Schrödinger to Receive Research Funding and Milestone Payments from ONO New York, NY － Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, today announced a research collaboration with Ono Pharmaceutical (ONO) to develop novel therapeutics. Under the terms of the agreement, the companies will work together to leverage Schrödinger’s computational […]
BC Platforms, a world leader in genomic data management and analysis solutions, announces co-operation with FinnGen program. FinnGen is a unique study that has been launched in Finland. Program will deepen our understanding about the origins of diseases and their treatment. The FinnGen study plans to tap into 500 000 unique blood samples collected by […]
Community-owned database empowers individuals with cryptocurrency for contributing genomic data SAN DIEGO — Luna DNA, the first and only genomic and medical research knowledge base powered by the blockchain and owned by its community, announced $2 Million in Seed funding today. The round included several individual investors and former executives from Illumina ILMN 0.34%, the world leader in DNA sequencing and […]
STRmix™ – the sophisticated forensic software used to resolve mixed DNA profiles previously thought to be too complex to interpret – has been used in a case in which a Brooklyn, NY man was convicted of murder for slashing the throat of his estranged wife. WASHINGTON STRmix™ – the sophisticated forensic software used to resolve […]
New York, NY － Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, announced today that it has received a payment from Sanofi for reaching a major milestone in its multi-year, multi-target drug discovery collaboration. The project in which the milestone was achieved is one of several programs that Schrödinger is […]
DNAnexus launches pilot of turn-key solution for deploying computationally intensive deep learning technology focused on genomic variation analysis MOUNTAIN VIEW, Calif.–DNAnexus, the global leader in genome informatics and data management, today announced the availability of the DeepVariant bioinformatics tool on the DNAnexus Platform. Developed by researchers at Google, DeepVariant is a deep learning technology that […]
Integration of Mosaic SampleBank™ with Genedata Screener® creates a best-in-class, off-the-shelf solution for automating plate management and plate data analysis Basel, Switzerland and London, United Kingdom Genedata and Titian Software today announced their technology partnership to create an automated, off-the-shelf solution for small molecule and biological inventory management and advanced screening data analysis. Their combined solution […]
This new awards program recognizes outstanding researchers in clinical and experimental pharmacology, and toxicology PRINCETON, NJ – Certara®, the global leader in model-informed drug development and regulatory science, announced that Leigh Farrell, PhD, Vice President of Corporate Strategy and Business Development, is presenting the inaugural Certara New Investigator Awards in association with the Australasian Society of […]
London, UK — Copenhagen Center for Glycomics (CCG) and Desktop Genetics (DTG) today announced a collaboration to develop the next-generation of CRISPR analysis. The project is designed to provide a deeper understanding of a novel method of identifying nuclease-generated mutations developed by the lab of Dr. Eric Paul Bennett. The method is currently used by CCG and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
